Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 13–13 | Cite as

Adalimumab

Various toxicities: 4 case reports
Case report

Reference

  1. Zhao CY, et al. Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas. Australasian Journal of Dermatology 59: e297-e298, No. 4, Nov 2018. Available from: URL: http://doi.org/10.1111/ajd.12829 -Australia

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations